Literature DB >> 16568235

Glycogen synthase kinase 3beta and Alzheimer's disease: pathophysiological and therapeutic significance.

Y Balaraman1, A R Limaye, A I Levey, S Srinivasan.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disorder associated with cognitive and behavioral dysfunction and is the leading cause of dementia in the elderly. Several studies have implicated molecular and cellular signaling cascades involving the serine-threonine kinase, glycogen synthase kinase beta(GSK-3beta) in the pathogenesis of AD. GSK-3beta may play an important role in the formation of neurofibrillary tangles and senile plaques, the two classical pathological hallmarks of AD. In this review, we discuss the interaction between GSK-3beta and several key molecules involved in AD, including the presenilins, amyloid precursor protein, tau, and beta-amyloid. We identify the signal transduction pathways involved in the pathogenesis of AD, including Wnt, Notch, and the PI3 kinase/Akt pathway. These may be potential therapeutic targets in AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16568235     DOI: 10.1007/s00018-005-5597-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  63 in total

1.  Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.

Authors:  Benjamin Combs; Kellen Voss; T Chris Gamblin
Journal:  Biochemistry       Date:  2011-10-17       Impact factor: 3.162

Review 2.  GSK-3β activity and hyperdopamine-dependent behaviors.

Authors:  Yan-Chun Li; Wen-Jun Gao
Journal:  Neurosci Biobehav Rev       Date:  2010-08-18       Impact factor: 8.989

3.  The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Int J Mol Med       Date:  2007-02       Impact factor: 4.101

Review 4.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

Review 5.  Platelet biomarkers in Alzheimer's disease.

Authors:  Leda L Talib; Helena Pg Joaquim; Orestes V Forlenza
Journal:  World J Psychiatry       Date:  2012-12-22

6.  (4Z,15Z)-Octadecadienoic Acid Inhibits Glycogen Synthase Kinase-3β and Glucose Production in H4IIE Cells.

Authors:  Jun Yoshida; Shota Uesugi; Tetsuaki Kawamura; Ken-Ichi Kimura; Dawei Hu; Shuang Xia; Naoki Toyooka; Masao Ohnishi; Hideki Kawashima
Journal:  Lipids       Date:  2017-02-13       Impact factor: 1.880

7.  Nicorandil inhibits oxidative stress and amyloid-β precursor protein processing in SH-SY5Y cells overexpressing APPsw.

Authors:  Jing-Jing Kong; Duo-Duo Zhang; Pai Li; Chun-Yang Wei; Hong-Jiu Yu; Hua Zhang; Wei Zhang; Yan-Fu Wang; Yun-Peng Cao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

8.  Possible association of the GSK3β gene with the anxiety symptoms of major depressive disorder and P300 waveform.

Authors:  Sha Liu; Ning Sun; Yong Xu; Chunxia Yang; Yan Ren; Zhifen Liu; Xiaohua Cao; Yan Sun; Qi Xu; Kerang Zhang; Yan Shen
Journal:  Genet Test Mol Biomarkers       Date:  2012-10-02

9.  CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways.

Authors:  Etrat Hooshmandi; Maryam Moosavi; Hermann Katinger; Shima Sardab; Rasoul Ghasemi; Nader Maghsoudi
Journal:  Mol Biol Rep       Date:  2020-02-17       Impact factor: 2.316

10.  Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Authors:  Thuy-Vi V Nguyen; Veronica Galvan; Wei Huang; Surita Banwait; Huidong Tang; Junli Zhang; Dale E Bredesen
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.